Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The panic and agoraphobia scale

International Clinical Psychopharmacology

Volumn 10, Issue 2, 1995, Pages 73-81

  Bandelow, B ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Agoraphobia; Panic; Scales; Treatment

Indexed keywords

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MULTICENTER STUDY; PANIC; PSYCHOMETRY; PSYCHOTHERAPY; RATING SCALE; REPRODUCIBILITY;

ADULT; AGORAPHOBIA; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MULTICENTER STUDIES; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTHERAPY; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 0029318448     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-199506000-00003     Document Type: Article

References (18)

1. Albus M, Maier W, Shera D, Becli P et al. (1990) Consistencies; and discrepancies in self- and observer-rated anxiety scales. European Archives of Psychiatry and Clinical Neurosciences, 240, 96-102.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. APA, Washington, DC.
3. American Psychiatric Association (1994) Diagnostic Criteria from DSMIV. APA, Washington, DC.
4. Argyle N, Deltito J., Allerup P, Maier W, Albus M., Nutzinger D, Rasmussen S, Ayuso JL and Bech P (1991) The panic-associated symptom scale: measuring the severity of panic disorder. Acta Psychiatnca Scahdinavica, 83, 20-26.
5. Bandelow B, Hajak G, Holzrichter S, Kunert HJ and Rüther E (1995) Assessing efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems. International Clinical Psychopharmacology, 10. 83-93.
6. Chambless DL., Caputo C, Jasin SE., Gracely EJ and Williams C (1985) The Mobility Inventory for Agoraphobia. Behaviour Research and Therapy, 23, 35-44.
7. Clark DM (1986) A cognitive approach to panic. Behaviour Research and Therapy, 24, 461-470.
8. Covi L, Lipman RS, McNair DM and Czerltnsky T (1979) Symptomatic volunteers in multicenter drug trials. Progress in Neuro-Psychopharmacology, 3. 521-533.
9. Derogatis LR., Lipman RS and Covi L (1976) Self-report symptom inventory. In ECDEU Assessment Manual for Psycho- pharmacology, revised edn (Ed. E Guy), pp. 313-331 Rockville, Maryland.
10. Hamilton M (1969) Diagnosis and rating of anxiety. British Journal of Psychiatry, Spec. Publ. 3, 76-79.
11. Moller HJ (1991) Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales. Pharmacopsychiatry, 24, 11-15.
12. National Institutes of Mental Health (1976) 028 CGI. Clinical Global Impressions. In: ECDEU Assessment Manual for Psychopharmacology, revised edn (Ed. E Guy), pp. 217-222. Rockville, Maryland.
13. Snaith RP, Baugh SJ, Clayden AD, Husain A and Sipple MA (1982) The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. British Journal of Psychiatry, 141, 518-523.
14. Spielberger CD, Gorsuch RL and Lushene RE (1978) State- Trait Anxiety Inventory (“Self-evaluation Questionnaire”), Consulting Psychologists Press, Palo Alto.
15. Taylor CB, Sheikh J, Agras WS, Roth WT, Margraf J, Ehlers A and Maddock RJ (1986) Ambulatory heart rate changes in patients with panic attacks. American Journal of Psychiatry, 143, 478-482.
16. World Health Organization (1991) Mental and behavioural disorders (including disorders of psychological development). Clinical descriptions and diagnostic guidelines. In: Tenth Revision of the International Classification of Diseases. WHO, Geneva.
17. World Health Organization (1993) Diagnostic criteria for research. In: The ICD-IO Classification of Mental and Behavioural Disorders. WHO, Geneva.
18. Zung WWK (1976) SAS—self-rating anxiety scale. In: ECDEU Assessment Manual for Psychopharmacology, revised ed (Ed. E Guy), pp. 337-340. Rockville, Maryland.